Revenue: As of FY2025 Q1, the actual value is USD 510.35 K.EPS: As of FY2025 Q1, the actual value is USD -1.52.EBIT: As of FY2025 Q1, the actual value is USD -1.506 M.<h3>Segment Revenue</h3><ul><li>Gross Sales: $534,943 for the three months ended March 31, 2025, primarily from the Elevai Acquisition products.</li><li>Net Sales: $510,353 after discounts and allowances of $24,590.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: $269,823 for the three months ended March 31, 2025.</li><li>Operating Expenses: Total operating expenses were $1,776,574, including selling and marketing expenses of $280,549, research and development expenses of $196,912, and general and administrative expenses of $1,275,161.</li><li>Loss from Operations: - $1,506,751 for the three months ended March 31, 2025.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: - $752,953 for the three months ended March 31, 2025.</li><li>Net Cash Used in Investing Activities: - $150,000 for the three months ended March 31, 2025, primarily related to the Elevai Acquisition.</li><li>Net Cash Provided by Financing Activities: $1,515,861 for the three months ended March 31, 2025, primarily from the 2025 Private Placement.</li></ul><h3>Unique Metrics</h3><ul><li>Elevai Acquisition: The acquisition included 38,308 shares of Common Stock issued and additional earnout liabilities of $301,633.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to focus on the commercialization of its cosmetic skincare and haircare products, leveraging the Elevai Acquisition to enhance revenue streams.</li><li>Non-Core Business: The company has paused further research and development on regenerative bone and tissue healing products to focus on near-term commercial potential products.</li><li>Priority: The company aims to achieve $500,000 in net revenue from sales of existing hair and scalp products by the 24-month anniversary of the Elevai Acquisition closing date.</li></ul>

LONGEVITY HEALTH HLDGS INC C/WTS 12/07/2028 (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 510.35 K